Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $740.0600 (1.25%) ($740.0600 - $740.1100) on Fri. Jun. 2, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.55% (three month average) | RSI | 48 | Latest Price | $740.0600(1.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(45%) DIA(30%) SPLV(28%) VYM(28%) | Factors Impacting REGN price | REGN will decline at least -0.775% in a week (0% probabilities). VXX(-24%) VIXM(-19%) TBT(-5%) ACES(-4%) UUP(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.775% (StdDev 1.55%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $743.43 | 5 Day Moving Average | $731.91(1.11%) | 10 Day Moving Average | $737.75(0.31%) | 20 Day Moving Average | $743.43(-0.45%) | To recent high | -10.9% | To recent low | 2% | Market Cap | $78.468b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |